MAM
Manas Lahiri back at Havas India as chief growth officer
MUMBAI: After years of charting remarkable successes across the advertising world, Manas Lahiri returns to where it all began—Havas India.
In a move that echoes both nostalgia and forward momentum, Lahiri steps back into the fold as chief growth officer, poised to reignite the spark of innovation and propel the network to greater heights.
A seasoned leader with a knack for transformative growth, Lahiri’s homecoming marks the beginning of a new chapter for one of India’s fastest-growing communications networks.
Lahiri’s appointment marks his return to Havas India, where he previously served in multiple roles, including MD of Havas Creative India (formerly Havas Worldwide India), between 2018 and 2023. In his new role, Lahiri will collaborate closely with the executive leadership team and report to Havas India, SEA, and north Asia group CEO, Rana Barua.
Barua welcomed Lahiri’s return, emphasising the significance of his role in the network’s growth trajectory, “Manas’ return to Havas India comes at a crucial time as we continue our strong momentum as a proven integrated and future-facing network. With Havas India’s phenomenal transformation over the past few years, we needed a proven leader to scale our growth ambitions further. Manas’ strategic acumen, extensive industry experience, and deep understanding of our network’s values make him the ideal choice to take on this role.”
Prior to rejoining Havas India, Lahiri held the position of executive growth partner at VML India, where he played a pivotal role in expanding the agency’s presence and securing key accounts. His career spans over two decades across advertising, brand marketing, and business leadership, including roles at Ogilvy, McCann, and Contract India. Lahiri has worked with marquee brands such as Samsung, Amazon, Coca-Cola, and Reckitt, providing him with a holistic perspective on brand strategy and growth.
Sharing his enthusiasm, Lahiri said, “I am thrilled to rejoin Havas India at such an exciting juncture. Havas has always been close to my heart, and the network’s journey of transformation into a consolidated, client-centric ecosystem is truly inspiring. I look forward to contributing to this next phase of growth by driving meaningful partnerships, fostering innovation, and building on the strong foundation created by Rana and the team.”
An MBA graduate from Bangalore University, Lahiri began his career on the client side, working with brands like Motorola and Samsung in sales and marketing before transitioning to advertising. During his previous tenure at Havas Creative India, Lahiri played a critical role in reshaping the agency, driving business wins, and strengthening client relationships. His expertise lies in fostering growth strategies, building high-performing teams, and delivering integrated solutions that yield tangible results.
This appointment underscores Havas India’s commitment to strengthening its leadership team and fostering innovation across its integrated network.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
